Humacyte Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio139.03591.2787.68
P/B Ratio-12.3421.711.866.111.85
Price/Tangible Book21.711.866.11
Enterprise Value Ratios
EV/Revenue61.81434.31
Profitability & Returns
Return on Equity (ROE)-1.70%-0.10%-0.27%-0.66%
Return on Assets (ROA)-0.54%-0.36%-0.22%-0.26%-0.29%
Return on Capital Employed (ROCE)-0.97%-0.88%-0.46%-0.29%-0.68%
Leverage & Solvency Ratios
Debt/Equity-1.544.290.430.420.41
Liquidity Ratios
Current Ratio2.404.517.8820.753.69
Quick Ratio2.254.367.7620.423.56
Efficiency Ratios
Asset Turnover0.010.010.01
Yield & Distribution Ratios
Earnings Yield-0.23%-0.38%-0.06%-0.04%-0.51%
FCF Yield-0.15%-0.26%-0.33%-0.11%-0.43%
Buyback Yield-0.15%0.00%-1.58%-5.93%0.71%